Yu-Waye Chu, Chief Medical Officer at CytomX Therapeutics, Inc. (CTMX), sold 42,558 shares at $6.42 ($273K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Open-market sale of $273k CTMX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.42 | 21,279 | $137K | 50.0% |
| 2 | $6.42 | 21,279 | $137K | 50.0% |
| Total | $6.42 avg | 42,558 | $273K | 100% |
| Filing → |
| FATE | SELL | 2023-01-11 | $41K | — | Filing → |
| FATE | SELL | 2022-04-21 | $287K | — | Filing → |
| FATE | SELL | 2022-01-13 | $364K | — | Filing → |